Mark Miller
Affiliations: | 2012-2018 | University of the Pacific, Stockton, CA, United States |
Google:
"Mark Miller"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Pal A, Albusairi W, Liu F, et al. (2019) Hydrophilic Small Molecules that Harness Transthyretin to Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents. Molecular Pharmaceutics |
Miller M, Pal A, Albusairi W, et al. (2018) Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis. Journal of Medicinal Chemistry |
Alhamadsheh M, Miller M, Pal A, et al. (2017) P5846AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy European Heart Journal. 38 |
Penchala SC, Miller MR, Pal A, et al. (2015) A biomimetic approach for enhancing the in vivo half-life of peptides. Nature Chemical Biology. 11: 793-8 |
Penchala SC, Miller MR, Pal A, et al. (2015) A biomimetic approach for enhancing the in vivo half-life of peptides Nature Chemical Biology |